IL84913A0 - Alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same - Google Patents

Alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same

Info

Publication number
IL84913A0
IL84913A0 IL84913A IL8491387A IL84913A0 IL 84913 A0 IL84913 A0 IL 84913A0 IL 84913 A IL84913 A IL 84913A IL 8491387 A IL8491387 A IL 8491387A IL 84913 A0 IL84913 A0 IL 84913A0
Authority
IL
Israel
Prior art keywords
processes
preparation
same
pharmaceutical composition
alkanesulfonanilide
Prior art date
Application number
IL84913A
Other languages
English (en)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868631083A external-priority patent/GB8631083D0/en
Priority claimed from GB878712647A external-priority patent/GB8712647D0/en
Priority claimed from GB878724903A external-priority patent/GB8724903D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of IL84913A0 publication Critical patent/IL84913A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20Quaternary compounds thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/071,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL84913A 1986-12-31 1987-12-22 Alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same IL84913A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868631083A GB8631083D0 (en) 1986-12-31 1986-12-31 2'-phenoxyalkanesulfonanilide derivatives
GB878712647A GB8712647D0 (en) 1987-05-29 1987-05-29 2'-phenoxyalkanesulfonanilide derivatives
GB878724903A GB8724903D0 (en) 1987-10-23 1987-10-23 2-phenoxyalkanesulfonanilide derivatives

Publications (1)

Publication Number Publication Date
IL84913A0 true IL84913A0 (en) 1988-06-30

Family

ID=27263273

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84913A IL84913A0 (en) 1986-12-31 1987-12-22 Alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same

Country Status (15)

Country Link
US (1) US4866091A (fi)
EP (1) EP0273369B1 (fi)
KR (1) KR910008138B1 (fi)
CN (1) CN87108295A (fi)
AR (1) AR243499A1 (fi)
AU (1) AU600782B2 (fi)
DE (1) DE3777122D1 (fi)
DK (1) DK693587A (fi)
ES (1) ES2033292T3 (fi)
FI (1) FI875719A (fi)
GR (1) GR3004051T3 (fi)
HU (1) HU200322B (fi)
IL (1) IL84913A0 (fi)
NO (1) NO168299C (fi)
PT (1) PT86407B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86462A (en) * 1987-05-29 1992-12-01 Fujisawa Pharmaceutical Co Alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
JPH0753725B2 (ja) * 1987-10-08 1995-06-07 富山化学工業株式会社 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
FI911633A (fi) * 1990-04-27 1991-10-28 Fujisawa Pharmaceutical Co Foerfarande foer framstaellning av alkansulfonanilidderivat.
US5374764A (en) * 1991-08-08 1994-12-20 Taisho Pharmaceutical Co., Ltd. 5-aminosulfonanilide compounds
US5449826A (en) * 1992-06-12 1995-09-12 Taisho Pharmaceutical Co., Ltd. 5-amino-2-phenoxysulfonanilide compound
US5604260A (en) * 1992-12-11 1997-02-18 Merck Frosst Canada Inc. 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
US5968958A (en) * 1995-01-31 1999-10-19 Merck Frosst Canada, Inc. 5-Methanesulfonamido-3H-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2
US5681842A (en) * 1996-11-08 1997-10-28 Abbott Laboratories Prostaglandin synthase-2 inhibitors
BR9809288A (pt) 1997-04-22 2001-08-07 Cocensys Inc Semicarbazonas e tiosemicarbazonas substituìdas carbocìclicas e heterocìclicas e utilização das mesmas
ES2158809B1 (es) * 1999-10-18 2002-03-16 Menarini Lab Nuevos derivados sulfonados como inhibidores de la ciclooxigenasa ii.
EP1635800A2 (en) * 2003-06-10 2006-03-22 Kalypsys, Inc. Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
US7470722B2 (en) 2004-06-10 2008-12-30 Kalypsys, Inc. Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
EP2493852B1 (en) * 2009-10-30 2014-04-09 Janssen Pharmaceutica NV 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
EP3040329B1 (en) * 2013-08-29 2018-10-10 Kyoto Pharmaceutical Industries, Ltd. Aromatic compound and use thereof in the treatment of disorders associated with bone metabolism
CN109912434B (zh) * 2017-12-13 2022-07-12 上海安谱实验科技股份有限公司 苯乙醇胺类β受体激动剂的合成方法
CN109608370A (zh) * 2019-01-22 2019-04-12 山西康斯亚森生物科技有限公司 尼美舒利衍生物和制备方法及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531523A (en) * 1967-07-18 1970-09-29 Upjohn Co N-(phenoxyphenyl)sulfamides
US3531522A (en) * 1967-07-18 1970-09-29 Upjohn Co 4'-phenoxyalkanesulfonanilides
US3840597A (en) * 1971-02-24 1974-10-08 Riker Laboratories Inc Substituted 2-phenoxy alkane-sulfonanilides
US3906024A (en) * 1971-02-24 1975-09-16 Minnesota Mining & Mfg Perfluoroalkanesulfonamidoaryl compounds
AR206496A1 (es) * 1972-07-03 1976-07-30 Riker Laboratories Inc Procedimiento para la preparacion de 2-fenoxi-4-nitro-alquil o haloalquilsulfonanilidas
US4465508A (en) * 1979-07-18 1984-08-14 Imperial Chemical Industries Plc Diphenyl ether herbicides
DE3114072A1 (de) * 1981-04-08 1982-11-04 Basf Ag, 6700 Ludwigshafen Herbizide diphenylether, deren herstellung und verwendung als herbizide
DE3466979D1 (en) * 1983-12-16 1987-12-03 Ciba Geigy Ag Process for the protection of keratinic material against the attack of keratin eating insects and phenoxytrifluoromethane sulfonanilides

Also Published As

Publication number Publication date
DK693587D0 (da) 1987-12-30
EP0273369A3 (en) 1989-10-18
EP0273369A2 (en) 1988-07-06
DK693587A (da) 1988-07-01
ES2033292T3 (es) 1993-03-16
AU8315287A (en) 1988-07-07
AU600782B2 (en) 1990-08-23
FI875719A0 (fi) 1987-12-28
KR910008138B1 (ko) 1991-10-10
HUT45971A (en) 1988-09-28
PT86407A (en) 1988-01-01
PT86407B (pt) 1990-11-20
NO168299B (no) 1991-10-28
CN87108295A (zh) 1988-07-13
DE3777122D1 (de) 1992-04-09
NO875488L (no) 1988-07-01
US4866091A (en) 1989-09-12
HU200322B (en) 1990-05-28
KR880007447A (ko) 1988-08-27
AR243499A1 (es) 1993-08-31
NO875488D0 (no) 1987-12-30
FI875719A (fi) 1988-07-01
EP0273369B1 (en) 1992-03-04
GR3004051T3 (fi) 1993-03-31
NO168299C (no) 1992-02-05

Similar Documents

Publication Publication Date Title
IL84522A0 (en) Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HK18194A (en) Substituted benzamide derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
IL83467A0 (en) Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same
IL77762A (en) 11beta-phenyl gonane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL83760A (en) 3-pyrazoliomethyl-3- cephem-4-carboxylate derivatives, process for the preparation thereof, and pharmacetuical compositions containing the same
IL80729A0 (en) Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL84589A0 (en) Pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
IL92939A0 (en) Thiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL92425A0 (en) Alpha-d-glucofuranose derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
IL84913A0 (en) Alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
IL88903A (en) Indolylpiperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
GB8917687D0 (en) Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
IL95548A0 (en) Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
EP0168005A3 (en) Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
IL78576A0 (en) 5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same
AU8146587A (en) New benzothiadiazine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
IL93321A0 (en) Acetamide derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL87563A (en) Isoxazole-b-carboline derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
EP0285089A3 (en) 4-thioquinazoline derivatives, processes for their preparation and pharmaceutical compositions
IL86173A (en) Pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA871756B (en) Arylazolylmethylbenzocycloalkene derivatives,processes for the preparation thereof,and the use thereof
GB2179347B (en) Methylenedioxyphenanthrene and -stilbene derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IL82294A0 (en) 1,3-dihydropyridine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
IL95088A0 (en) Pyrroloquinoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA875790B (en) Imidazole compounds,processes for the preparation thereof and pharmaceutical composition comprising the same